Core Viewpoint - The recent private enterprise symposium in Beijing, chaired by President Xi Jinping, emphasizes strong support for the development of private enterprises, which is seen as a significant opportunity for companies like Jiuzhoutong [1] Group 1: Company Strategy - Jiuzhoutong, the largest private pharmaceutical distribution company in China, is committed to advancing its "three new and two digitalization" strategy, which includes new products, new retail, new healthcare, digitalization, and real estate securitization (REITs) [1] - The company aims to transform from traditional pharmaceutical distribution to a more digital, platform-based, and internet-driven model [1] Group 2: Industry Focus - The symposium highlighted the importance of "sticking to the main business and strengthening the real economy," reinforcing Jiuzhoutong's commitment to focus on development and core business [1] - Jiuzhoutong plans to leverage modern logistics, information technology, the internet, big data, and artificial intelligence to explore new tracks, new formats, and new models in the health industry [1] Group 3: Governance and Risk Management - Modernizing the corporate governance system was a key focus for participating entrepreneurs, and Jiuzhoutong has responded by establishing a modern governance framework and improving its corporate governance structure and risk prevention mechanisms [1]
九州通董事长刘长云: 抢抓机遇 推进“三新两化”战略实施